NANOCOPOEIA

nanocopoeia-logo

Nanocopoeia recently reorganized and restructured to scale-up technology, generate macro-particles for oral-solid drug development. They have demonstrated a strong proof-of-concept in enhancing low solubility drug performance and solid progress across their target drug pipeline.

#SimilarOrganizations #People #Financial #Website #More

NANOCOPOEIA

Industry:
Health Care Medical Pharmaceutical

Founded:
2001-01-01

Address:
Saint Paul, Minnesota, United States

Country:
United States

Website Url:
http://www.nanocopoeia.com

Total Employee:
11+

Status:
Active

Contact:
+1 651 209 1184

Email Addresses:
[email protected]

Total Funding:
500 K USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt WordPress Font Awesome Wordpress Plugins Nginx WP Engine Hubspot Forms Linode


Similar Organizations

not_available_image

Phapros

Phapros is a pharmaceutical company.


Current Advisors List

jim-schwier_image

Jim Schwier COO @ Nanocopoeia
Advisor

christian-wertz_image

Christian Wertz Pharmaceutical Sciences @ Nanocopoeia
Advisor

not_available_image

Michael Graves Board of Directors @ Nanocopoeia
Board_member

not_available_image

Joseph McTarsney Senior Scientist II @ Nanocopoeia
Advisor
2017-05-01

Current Employees Featured

not_available_image

Da-Ren Chen
Da-Ren Chen Co-Founder @ Nanocopoeia
Co-Founder

not_available_image

Michael Graves
Michael Graves Chairman @ Nanocopoeia
Chairman

david-y-h-pui_image

David Y. H. Pui
David Y. H. Pui Co-Founder @ Nanocopoeia
Co-Founder

not_available_image

Karen M. Arnold
Karen M. Arnold Co-Founder and CFO @ Nanocopoeia
Co-Founder and CFO

not_available_image

Robert Hoerr
Robert Hoerr Chief Scientific Officer & Co-Founder @ Nanocopoeia
Chief Scientific Officer & Co-Founder
2002-01-01

Founder


not_available_image

Da-Ren Chen

david-y-h-pui_image

David Y. H. Pui

not_available_image

Karen M. Arnold

not_available_image

Robert Hoerr

Investors List

national-science-foundation_image

National Science Foundation

National Science Foundation investment in Grant - Nanocopoeia

small-business-innovation-research_image

Small Business Innovation Research

Small Business Innovation Research investment in Grant - Nanocopoeia

Official Site Inspections

http://www.nanocopoeia.com

  • Host name: 141.193.213.10
  • IP address: 141.193.213.10
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Nanocopoeia"

Nanocopoeia - Crunchbase Company Profile & Funding

Organization. Nanocopoeia . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. …See details»

Nanocopoeia Technology – Nanocopoeia

Nanocopoeia, LLC 639 Campus Drive New Brighton, MN 55112 651.209.1184 [email protected]See details»

Nanocopoeia - Contacts, Employees, Board Members, Advisors

Nanocopoeia is a pharmaceutical company. New. Resources. Advanced Search. Start Free Trial . Talk With Sales ... Experience the new Crunchbase, powered by AI . Experience the new …See details»

Nanocopoeia LLC - LinkedIn

Nanocopoeia LLC Pharmaceutical Manufacturing New Brighton, MN 96 followers Specializing in solving high-value / high-barrier, insolubility, bioavailability, and related drug product issuesSee details»

NANOCOPOEIA, LLC Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for NANOCOPOEIA, LLC of New Brighton, MN. Get the latest business insights from Dun & …See details»

Nanocopoeia, LLC | TREA

Electrohydrodynamic atomization nozzle emitting a liquid sheet. Patent number 10,562,048; Issue date Feb 18, 2020; Nanocopoeia, LLC Daren ChenSee details»

Nanocopoeia Inc - CAGE.report

Nanocopoeia Inc DUNS 142300511 / 14-230-0511. NCAGE Code: 4B2Q7. NANOCOPOEIA INC. CAGE Code: 4B2Q7. NANOCOPOEIA INC. DUNS: 142300511. Nanocopoeia Inc. Company …See details»

Nanocopoeia, Inc. - Drug pipelines, Patents, Clinical trials - Synapse

Explore Nanocopoeia, Inc. with its drug pipeline, therapeutic area, technology platform, 2 news, and 5 literature, Disease Domain:Hemic and Lymphatic Diseases, Immune ...See details»

Nanocopoeia, LLC - CMOCRO

Nanocopoeia is a drug delivery company providing nano-enabled particle design, services, and equipment to the pharmaceutical industry. Company\'s patented ENS process is a flexible, low …See details»

Nanocopoeia - Products, Competitors, Financials, Employees ...

Nanocopoeia primarily serves the pharmaceutical and medical device industries with its technology solutions. It is based in Saint Paul, Minnesota. Headquarters Location. 1246 …See details»

Nanocopoeia, Inc.

Nanocopoeia, Inc. 1246 West University Avenue Suite 301 St. Paul, MN 55104 Phone: (651) 209-1184 Fax: (651)209-1187 E-mail: [email protected] Nanocopoeia Homepage. …See details»

Nanocopoeia Management Team | Org Chart - RocketReach

Nanocopoeia employs 14 employees. The Nanocopoeia management team includes Christian Wertz (VP Pharmaceutical Sciences), Sarah Rieschl (Sr. Scientist), and Limin Shi (Principal …See details»

Nanocopoeia Inc. - VentureRadar

Nanocopoeia provides a proprietary ElectroNanospray(TM) formulation technology that can be used to improve bioavailability and speed up onset of action of drugs. Nanoparticles are …See details»

Nanocopoeia Information - RocketReach

The NAICS codes for Nanocopoeia are [3254, 32, 32541, 325]. What is the SIC code for Nanocopoeia? The SIC codes for Nanocopoeia are [28, 283]. Top Nanocopoeia Employees …See details»

Nanocopoeia - Overview, News & Similar companies - ZoomInfo

Nanocopoeia is a drug delivery company with a nanotechnology enabled portfolio of dermal and transdermal therapeutic products. Our business model i s to enhance the value and …See details»

Nanocopoeia Inc. : Quotes, Address, Contact

Built on a foundation of revolutionary intellectual property, Nanocopoeia has grown into a major nanotechnology player in just 10 years. With beginnings at the University of Minnesota dating …See details»

Nanocopoeia Inc. | SBIR.gov

This Small Business Innovation Research (SBIR) Phase I Project will develop a manufacturing process using electrospray for reliably producing nano-suspensions as well as a novel solid …See details»

Dasatinib - Nanocopoeia - AdisInsight - Springer

Jan 15, 2025 11 Oct 2023 Nanocopoeia resubmits NDA for treatment of patients with Chronic myeloid leukaemia (In adults, First-line therapy, Second-line therapy or greater) and Precursor …See details»

Nanocopoeia Inc. University and Research Institutes

Main Activity in Nanotechnology. Drug Delivery Technology. About Company. Built on a foundation of revolutionary intellectual property, Nanocopoeia has grown into a major …See details»

The emerging era of structural nanomedicine - Nature

Apr 25, 2025 The lack of structural definition in nanomedicines limits therapeutic efficacy and complicates regulatory approval. Here, we emphasize that defining, designing and optimizing …See details»

linkstock.net © 2022. All rights reserved